论文信息 - Prognostic factors for tumour response, progression-free survival and toxicity in metastatic colorectal cancer patients given irinotecan (CPT-11) as second-line chemotherapy after 5FU failure - 字舞流文

Prognostic factors for tumour response, progression-free survival and toxicity in metastatic colorectal cancer patients given irinotecan (CPT-11) as second-line chemotherapy after 5FU failure

S. Culine | P. Hérait | M. Marty | P. Rougier | J. Droz | R. Bugat | V. Trillet-lenoir | G. Freyer | L. Awad | H. Bleiberg | D. Mignard | V. Trillet‐Lenoir | F220 F221 and V222 study groups the CPT-11 F205